BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1055 related articles for article (PubMed ID: 33159022)

  • 21. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma.
    Xu H; Wang H; Zhao W; Fu S; Li Y; Ni W; Xin Y; Li W; Yang C; Bai Y; Zhan M; Lu L
    Theranostics; 2020; 10(13):5671-5686. PubMed ID: 32483411
    [No Abstract]   [Full Text] [Related]  

  • 22. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METTL3 and METTL14 regulate IL-6 expression via RNA m6A modification of zinc transporter SLC39A9 and DNA methylation of IL-6 in periodontal ligament cells.
    Huang J; Wang Y; Zhou Y
    Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119605. PubMed ID: 37821055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases.
    Wang P; Doxtader KA; Nam Y
    Mol Cell; 2016 Jul; 63(2):306-317. PubMed ID: 27373337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.
    Feng Z; Li Q; Meng R; Yi B; Xu Q
    J Cell Mol Med; 2018 May; 22(5):2558-2568. PubMed ID: 29502358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into roles of METTL14 in tumors.
    Liu X; Du Y; Huang Z; Qin H; Chen J; Zhao Y
    Cell Prolif; 2022 Jan; 55(1):e13168. PubMed ID: 34904301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions, localization, and phosphorylation of the m
    Schöller E; Weichmann F; Treiber T; Ringle S; Treiber N; Flatley A; Feederle R; Bruckmann A; Meister G
    RNA; 2018 Apr; 24(4):499-512. PubMed ID: 29348140
    [No Abstract]   [Full Text] [Related]  

  • 28. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Xie W; Ma LL; Xu YQ; Wang BH; Li SM
    Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of G-quadruplex RNA by a crucial RNA methyltransferase component, METTL14.
    Yoshida A; Oyoshi T; Suda A; Futaki S; Imanishi M
    Nucleic Acids Res; 2022 Jan; 50(1):449-457. PubMed ID: 34908152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma.
    Wu X; Zhang X; Tao L; Dai X; Chen P
    Biomed Res Int; 2020; 2020():2053902. PubMed ID: 32733931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The N
    Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
    Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of N6-adenosine-methyltransferase subunits METTL3 and METTL14 in the biological properties of periodontal ligament cells.
    Huang J; Guo C; Wang Y; Zhou Y
    Tissue Cell; 2023 Jun; 82():102081. PubMed ID: 37018927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple m
    Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
    BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRMT1 methylates METTL14 to modulate its oncogenic function.
    Wang J; Wang Z; Inuzuka H; Wei W; Liu J
    Neoplasia; 2023 Aug; 42():100912. PubMed ID: 37269817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Miao W; Chen J; Jia L; Ma J; Song D
    Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.
    Hu J; Yang L; Peng X; Mao M; Liu X; Song J; Li H; Chen F
    Hum Cell; 2022 Nov; 35(6):1838-1855. PubMed ID: 36087219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Alternatively Spliced Variant of METTL3 Mediates Tumor Suppression in Hepatocellular Carcinoma.
    Xu RY; Ding Z; Zhao Q; Ke TY; Chen S; Wang XY; Wang YY; Sheng MF; Wang W; Long N; Shen YX; Xu YZ; Shao W
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.